Ivantis Announces Results of Hydrus Implant Study

Last week, Ivantis announced the 6-month results from its multi-center, international Hydrus I study at the European Society of Cataract and Refractive Surgery Meeting (ESCRS). The Hydrus(TM) Intracanalicular Implant, roughly the size of an eyelash, is placed through a minimally invasive, microsurgical procedure and is designed to reduce eye pressure by reestablishing the patient’s conventional outflow pathway. The Hydrus device relies on a twofold mechanism of action that creates a relatively large opening through the trabecular meshwork, and then dilates and scaffolds Schlemm’s canal.